slides · global inventory
Title
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 303,780
Current window 43,741-43,770
Pages 10,126
Rows per page 30
Component
43,741-43,770 of 303,780
09
The slide uses a table to highlight the unique value proposition of four specific clinical programs.Exscientia | Investor Presentation Deck | 76 slides · Exscientia
Pitch deck Investor relations Loop · Cost Of Inaction2 hits
10
The chart uses a horizontal bar format to represent the development stage of each program.Exscientia | Investor Presentation Deck | 76 slides · Exscientia
Pitch deck Investor relations 2 hits
11
The diagram is a concentric circle model representing the layers of value in collaborations.Exscientia | Investor Presentation Deck | 76 slides · Exscientia
Pitch deck Investor relations Beat · Business Model2 hits
12
The slide uses a stepped arrow diagram to show progression from known targets to challenging novel targets.Exscientia | Investor Presentation Deck | 76 slides · Exscientia
Pitch deck Investor relations 2 hits
13
Includes footnote regarding fixed term bank deposits and currency basis.Exscientia | Investor Presentation Deck | 76 slides · Exscientia
Pitch deck Investor relations 2 hits
15
The slide uses a complex flow diagram combining a linear process with two internal feedback loops (Active Learning).Exscientia | Investor Presentation Deck | 76 slides · Exscientia
Pitch deck Investor relations 2 hits
16
The slide uses a circular process flow to represent a proprietary R&D pipeline.Exscientia | Investor Presentation Deck | 76 slides · Exscientia
Pitch deck Investor relations 2 hits
18
The slide uses Kaplan-Meier curves to demonstrate clinical efficacy of the platform's drug prioritization.Exscientia | Investor Presentation Deck | 76 slides · Exscientia
Pitch deck Investor relations 2 hits
19
The slide uses a horizontal process-like layout to showcase four distinct technical pillars.Exscientia | Investor Presentation Deck | 76 slides · Exscientia
Pitch deck Investor relations 2 hits
20
The slide uses a circular flow diagram to represent the integration of AI and experimental biology.Exscientia | Investor Presentation Deck | 76 slides · Exscientia
Pitch deck Investor relations 2 hits
21
The diagram illustrates a flywheel-like process of data integration leading to novel targets.Exscientia | Investor Presentation Deck | 76 slides · Exscientia
Pitch deck Investor relations 2 hits
22
The slide uses a hierarchical clustering heatmap (dendrograms on top and left) to visualize drug sensitivity across 80 small molecules.Exscientia | Investor Presentation Deck | 76 slides · Exscientia
Pitch deck Investor relations 2 hits
23
The slide illustrates a computational drug discovery workflow using MPO (Multiparameter Optimisation).Exscientia | Investor Presentation Deck | 76 slides · Exscientia
Pitch deck Investor relations 2 hits
24
The diagram uses a hub-and-spoke model to show data integration, followed by a funnel for molecule generation and a circular feedback loop for active learning.Exscientia | Investor Presentation Deck | 76 slides · Exscientia
Pitch deck Investor relations 2 hits
26
The scatter plot highlights a specific cluster of 'active learning' selections that deviate from the standard Pareto frontier.Exscientia | Investor Presentation Deck | 76 slides · Exscientia
Pitch deck Investor relations 2 hits
27
The slide uses a small multiples approach to show dose-response curves across multiple patient samples, followed by a summary plot comparing the two groups over time.Exscientia | Investor Presentation Deck | 76 slides · Exscientia
Pitch deck Investor relations 2 hits
31
The slide outlines a standard oncology clinical trial design (Phase 1/2) with a transition point at RP2D (Recommended Phase 2 Dose).Exscientia | Investor Presentation Deck | 76 slides · Exscientia
Pitch deck Investor relations 2 hits
32
The slide uses a human anatomy diagram to map specific cancer types to their respective organs, totaling approximately 75,000 patients annually.Exscientia | Investor Presentation Deck | 76 slides · Exscientia
Pitch deck Investor relations 2 hits
33
Includes a biological pathway diagram and a honeycomb diagram for indications.Exscientia | Investor Presentation Deck | 76 slides · Exscientia
Pitch deck Investor relations 2 hits
34
The slide uses a three-column layout to define technical constraints for drug development.Exscientia | Investor Presentation Deck | 76 slides · Exscientia
Pitch deck Investor relations 2 hits
35
The table uses a color-coded heatmap to indicate performance against criteria.Exscientia | Investor Presentation Deck | 76 slides · Exscientia
Pitch deck Investor relations 2 hits
36
The slide presents preclinical efficacy data for a CDK7 inhibitor ('617) in ovarian (OVCAR3) and triple-negative breast cancer (HCC70) models.Exscientia | Investor Presentation Deck | 76 slides · Exscientia
Pitch deck Investor relations 2 hits
37
The chart is a waterfall plot showing drug response scores across many patient samples, color-coded by diagnosis.Exscientia | Investor Presentation Deck | 76 slides · Exscientia
Pitch deck Investor relations 2 hits
38
The slide uses a heatmap to correlate '617 sensitivity with synergy outcomes for three different drug combinations.Exscientia | Investor Presentation Deck | 76 slides · Exscientia
Pitch deck Investor relations 2 hits
39
Venn diagram shows overlap of gene modulation; line charts show dose-response for POLR2A and HNRNPDL.Exscientia | Investor Presentation Deck | 76 slides · Exscientia
Pitch deck Investor relations 2 hits
41
The slide showcases a successful asset development case study involving AI-driven design.Exscientia | Investor Presentation Deck | 76 slides · Exscientia
Pitch deck Investor relations 2 hits
42
The slide uses a traffic-light color coding system to highlight the competitive advantage of the company's drug candidate.Exscientia | Investor Presentation Deck | 76 slides · Exscientia
Pitch deck Investor relations 2 hits
43
The slide uses a process-oriented layout to explain the company's methodology.Exscientia | Investor Presentation Deck | 76 slides · Exscientia
Pitch deck Investor relations 2 hits
44
The background features a 3D molecular visualization, likely representing the LSD1 protein or the drug binding to it.Exscientia | Investor Presentation Deck | 76 slides · Exscientia
Pitch deck Investor relations 2 hits
46
The slide uses a human anatomy diagram to map specific disease indications to their respective patient counts.Exscientia | Investor Presentation Deck | 76 slides · Exscientia
Pitch deck Investor relations 2 hits